COVID-19 Progress has been mostly positive. Novavax and Johnson & Johnson both made progress on vaccines. AstraZeneca-Oxford’s vaccine was also approved by a European regulator. US daily cases are in a downward trajectory and may fall below 100,000 new cases a day in the next ten days. The ratio of vaccines to new cases is at 9x and could exceed 10x as early as next week. We are happy to report that COVID-19 cases have now been falling for 17 consecutive days. We are now definitely seeing the strongest retreat in cases since Wave 2.

The video in this report is only accessible to members

Despite this positive news, we are still seeing some ‘growing pains’ in the US vaccination process. Moderna and Pfizer’s vaccines are the only ones approved for EUA in the US. Right now, this is contributing to supply-constraints. The Biden administration recently announced that weekly deliveries should reach 10 million doses, higher than the current level of around 8 million. Until more vaccines are approved in the United States, delivered vaccines can be considered a ‘ceiling’ and until that number grows the number of doses is essentially constrained. On Thursday, nearly one and a half million Americans received a dose.

The video in this report is only accessible to members
STRATEGY: 2021 is already proving to be as challenging as 2020… Millennials are structurally chang...

Unlock this article with a FREE 30-Day Trial!

An FSI Pro, or FSI Macro subscription is required in order to access this content.

*Free trial available only on a monthly plan

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Want to receive Regular Market Updates to your Inbox?

I am your default error :)